Zentalis Pharmaceuticals提交2.5亿美元混合证券货架

2025-03-27 04:31

Zentalis Pharmaceuticals (NASDAQ:ZNTL) filed a prospectus for the offer and sale of $250M mixed securities shelf.
This preliminary prospectus is not an offer to sell.
Filing.

More on Zentalis Pharmaceuticals

Zentalis to cut 40% of workforce, focus on azenosertib
Zentalis Pharmaceuticals and PureTech Health get Fast Track Designation from FDA for their cancer treatments
Seeking Alpha’s Quant Rating on Zentalis Pharmaceuticals
Historical earnings data for Zentalis Pharmaceuticals
Financial information for Zentalis Pharmaceuticals